Agenda Details | ASGCT Annual Meeting

Detailed Program

Thursday, May 09 2024
08:00 AM – 09:45 AM ET
Ballroom 2

Gene Editing Technologies (Organized by the Education Committee)

The CRISPR field has evolved to safer systems with lower off-target effects, and human trials are showing efficacy in vivo. An update of current base-editing methods and specific in vivo approaches to treat genetic diseases will be covered.

Learning Objectives: (3-4 preferred)

Basics of gene editing
Mechanisms of different CRISPR/Cas systems
Basis for disease treatment using CRISPR (CF and Transthyretin Amyloidosis)

Session Details

08:00 AM - 09:45 AM - Ballroom 2

Nuria Morral - PhD - Indiana University School of Medicine

Co-Chair

08:00 AM - 09:45 AM - Ballroom 2

Dimitrios Wagner - Center for Cell and Gene Therapy

Co-Chair

08:10 AM - 08:40 AM - Ballroom 2

Samantha Maragh - PhD - NIST

How Confident Are You? Expanded Results From The First NIST Genome Editing Consortium Interlab Study

08:40 AM - 09:10 AM - Ballroom 2

Anna Cereseto - University of Trento

Gene editing for Cystic Fibrosis

09:10 AM - 09:40 AM - Ballroom 2

David Corey - PhD - Harvard Medical School

Session Details

Detailed Program

Gene Editing Technologies (Organized by the Education Committee)

Session Details

Co-Chair

Co-Chair

How Confident Are You? Expanded Results From The First NIST Genome Editing Consortium Interlab Study

Gene editing for Cystic Fibrosis

Gene editing for hereditary deafness